混合完全胸腔镜迷宫和持续性心房动的导管切除:初步经验
Adrian W Pick1, Emily Kotschet2, Stewart Healy2
1Victorian Heart Hospital, Melbourne, Vic, Australia; Cabrini Medical Centre, Melbourne, Vic, Australia; Peninsula Private Hospital, Melbourne, Vic, Australia.
Heart, lung & circulation
|July 17, 2023
概括
混合废除技术结合了内心和心表的方法,用于持续性心房动 (AF). 这种方法显示出出色的早期结果和持久的成功,克服了隔离的导管干预的局限性.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 电力生理学 电力生理学
背景情况:
- 心房动 (AF) 是老龄化人口中日益蔓延的流行病.
- 虽然存在手术和导管切除,但对于持续性AF的隔离内心方法有局限性.
- 其中包括漫长的程序时间,风险和结果的不理想持久性.
研究的目的:
- 评估对持续性心房动 (AF) 进行混合除策略的疗效.
- 将左心室内心脏和上心脏干预与分阶段映射相结合.
- 为了优化手术和导管式除方法的好处.
主要方法:
- 一系列患有持续性心房动的患者接受了混合除手术.
- 这种方法结合了内心导管切除与心上外科切除.
- 使用分阶段映射来指导和优化废弃策略.
主要成果:
- 在最初的患者系列中,混合除程序表现出了很好的早期结果.
- 患者在术后经历了无并发症的体验.
- 在随访期间观察到非常好的成功率,表明持久的结果.
结论:
- 混合除方法是治疗持续性心房动的一个有希望的策略.
- 结合内心和上心干预提供了一个优化的解决方案.
- 这种技术为患有持续性AF的患者提供了出色的成功率和无并发症.
更多相关视频
相关概念视频
01:25Dysrhythmias VI: Management of Dysrhythmias
19
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
19
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16